PL2123673T3 - Peptydy inhibujące egzocytozę neuronalną - Google Patents

Peptydy inhibujące egzocytozę neuronalną

Info

Publication number
PL2123673T3
PL2123673T3 PL07823010T PL07823010T PL2123673T3 PL 2123673 T3 PL2123673 T3 PL 2123673T3 PL 07823010 T PL07823010 T PL 07823010T PL 07823010 T PL07823010 T PL 07823010T PL 2123673 T3 PL2123673 T3 PL 2123673T3
Authority
PL
Poland
Prior art keywords
inhibiting peptides
neuronal exocytosis
exocytosis inhibiting
neuronal
peptides
Prior art date
Application number
PL07823010T
Other languages
English (en)
Inventor
Serraima Christina Carreño
Obiols Berta Ponsati
Den Nest Wim Van
Carneado Jimena Fernandez
Montiel Antonio Ferrer
Puche Joan Cebrian
Domenech Nuria Almiñana
Original Assignee
Bcn Peptides, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bcn Peptides, S.A. filed Critical Bcn Peptides, S.A.
Publication of PL2123673T3 publication Critical patent/PL2123673T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
PL07823010T 2006-10-25 2007-10-24 Peptydy inhibujące egzocytozę neuronalną PL2123673T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200602720A ES2322882B1 (es) 2006-10-25 2006-10-25 Peptidos inhibidores de la exocitosis neuronal.
EP07823010.9A EP2123673B1 (en) 2006-10-25 2007-10-24 Neuronal exocytosis inhibiting peptides

Publications (1)

Publication Number Publication Date
PL2123673T3 true PL2123673T3 (pl) 2017-06-30

Family

ID=39324166

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07823010T PL2123673T3 (pl) 2006-10-25 2007-10-24 Peptydy inhibujące egzocytozę neuronalną

Country Status (27)

Country Link
US (1) US9464129B2 (pl)
EP (1) EP2123673B1 (pl)
JP (1) JP5647413B2 (pl)
KR (1) KR101606448B1 (pl)
CN (1) CN101541831B (pl)
AR (1) AR063528A1 (pl)
AU (1) AU2007310796B2 (pl)
BR (1) BRPI0717376B8 (pl)
CA (1) CA2666516C (pl)
CL (1) CL2007003054A1 (pl)
CY (1) CY1118690T1 (pl)
DK (1) DK2123673T3 (pl)
ES (2) ES2322882B1 (pl)
HR (1) HRP20170378T1 (pl)
HU (1) HUE031340T2 (pl)
IL (1) IL198191A (pl)
LT (1) LT2123673T (pl)
MX (1) MX2009004424A (pl)
NZ (1) NZ576373A (pl)
PL (1) PL2123673T3 (pl)
PT (1) PT2123673T (pl)
RS (1) RS55755B1 (pl)
RU (1) RU2461568C2 (pl)
SI (1) SI2123673T1 (pl)
TW (1) TWI439291B (pl)
WO (1) WO2008049945A1 (pl)
ZA (1) ZA200903236B (pl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019016A (en) 1990-04-10 1991-05-28 Gkn Automotive Inc. Anti-shudder tripod constant velocity universal joint
ES2356883B1 (es) * 2008-07-24 2012-02-22 Bcn Peptides, S.A. Composición para el tratamiento del dolor y/o la inflamación.
US20110305735A1 (en) 2010-06-09 2011-12-15 Lipotec, S.A. Skin antiaging treatment
FR2961510A1 (fr) * 2010-06-17 2011-12-23 Oreal Utilisation comme agent de traitement de la transpiration humaine ; nouveaux derives d'acide amine ; compositions les contenant
ES2385683B1 (es) * 2010-10-18 2013-10-07 Bcn Peptides, S.A. Composiciones para el tratamiento del dolor y/o la inflamación.
US20130287714A1 (en) * 2010-11-12 2013-10-31 Sven Gohla Cosmetic and/or dermatological preparations containing snow algae extract
WO2013070808A1 (en) * 2011-11-07 2013-05-16 Feng Tian Peptide-based compounds as inhibitors of neurotransmitter secretion
ES2424294B1 (es) 2012-03-22 2014-07-21 Lipotec, S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
EP2649983A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
WO2013156064A1 (en) 2012-04-17 2013-10-24 Activen Anti-wrinkles cosmetic composition comprising a mu-conopeptide
EP2649985A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2649984A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
US10149812B2 (en) 2012-04-13 2018-12-11 Activen Cosmetic composition comprising a muconopeptide
ES2660901T3 (es) * 2012-04-13 2018-03-26 Lubrizol Advanced Materials, Inc. Compuestos que inhiben la exocitosis neuronal (II)
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
HUE034308T2 (en) 2013-03-21 2018-02-28 Sanofi Aventis Deutschland Preparation of hydantoin-containing peptide products
US20160250298A1 (en) 2013-11-01 2016-09-01 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CN103641888B (zh) * 2013-12-03 2015-08-12 广州健坤生物科技有限公司 一种多功能新型小肽、包含该肽的组合物及其应用
CN103637925B (zh) * 2013-12-03 2015-09-30 广州健坤生物科技有限公司 γ-氨基丁酸(GABA)和一种小肽在化妆品中的联合应用
CN103694316B (zh) * 2013-12-31 2015-09-09 杭州华津药业股份有限公司 一种阿基瑞林的制备方法
RU2551276C1 (ru) * 2014-02-03 2015-05-20 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения диацетата трипептида
ES2642916T3 (es) * 2014-06-06 2017-11-20 Galit KLEINER-FISMAN Toxina botulínica para su uso en el tratamiento de la paratonia
CA2965525A1 (en) 2014-10-31 2016-05-06 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane film for delivery of active agents to skin surfaces
KR101747411B1 (ko) * 2015-04-13 2017-06-14 주식회사 엘지생활건강 신경전달물질을 조절하는 펩타이드의 신경세포 전달용 용해성 미세바늘
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3371238A1 (en) 2015-11-05 2018-09-12 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
RU2633691C2 (ru) * 2015-12-17 2017-10-16 Федеральное государственное автономное образовательное учреждение высшего образования "Балтийский федеральный университет имени Иммануила Канта" (БФУ им. И. Канта) Способ генетического контроля экзоцитоза на основе генетических конструкций для трансфекции клеток астроглии
KR101895906B1 (ko) * 2016-07-07 2018-10-04 주식회사 한국화장품제조 펩타이드 리포좀을 포함하는 스틱형 화장료 조성물
KR102607079B1 (ko) * 2016-09-09 2023-11-28 주식회사 엘지생활건강 신경세포 투과성이 향상된 신경전달물질 조절 펩타이드
JP7227903B2 (ja) * 2016-11-30 2023-02-22 ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド 皮膚、毛髪、爪および／もしくは粘膜の処置ならびに／またはケアに有用な化合物
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2019004758A2 (ko) * 2017-06-28 2019-01-03 주식회사 엘지생활건강 피부투과 촉진용 펩타이드가 결합된 융합 단백질을 포함하는 피부개선용 화장료 조성물
AU2019228281B2 (en) 2018-02-27 2024-06-13 Lipotrue, S.L. Peptides and compositions for use in cosmetics and medicine
ES3060502T3 (en) * 2018-06-13 2026-03-26 Acraf Peptides having inhibitory activity on neuronal exocytosis
CN109021071B (zh) * 2018-08-21 2020-08-04 山西锦波生物医药股份有限公司 肽及其制备方法和用途
ES3032335T3 (en) * 2019-12-04 2025-07-17 Lipotrue S L Peptides and compositions for use in cosmetics and medicine
WO2022162312A1 (fr) * 2021-01-27 2022-08-04 Fabien Schweighoffer Peptides et leurs utilisations
CN113512092A (zh) * 2021-06-28 2021-10-19 陕西未来多肽生物科技有限公司 多肽纳米杂化物及其用途
CN113402586A (zh) * 2021-06-28 2021-09-17 陕西未来多肽生物科技有限公司 一种多肽及其应用
CN114933634B (zh) * 2021-11-18 2024-08-09 陕西未来多肽生物科技有限公司 一种乙酰基十六肽的合成方法
CN113929749B (zh) * 2021-11-18 2024-08-09 陕西未来多肽生物科技有限公司 一种十六肽化合物及其制备方法
EP4230638A1 (en) 2022-02-16 2023-08-23 Lipotrue, S.L. Peptides and compositions for use in cosmetics
WO2023155881A1 (en) * 2022-02-18 2023-08-24 Tsinghua University Methods for regulating secretion via migrasomes
EP4501944A4 (en) 2022-03-28 2025-10-08 Shenzhen Winkey Tech Co Ltd POLYPEPTIDE AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND THEIR USE
WO2024011300A1 (en) * 2022-07-13 2024-01-18 L'oreal Modified peptides, composition, method for inhibiting contraction of muscle cells, method for improving the skin and use of a modified peptide
CN118063547A (zh) * 2024-03-01 2024-05-24 深圳市维琪科技股份有限公司 环八肽及其组合物和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0258111A3 (en) * 1986-08-07 1989-01-25 FIDIA S.p.A. Novel neuronotrophic factor
EP0446931A1 (en) * 1990-03-14 1991-09-18 FIDIA S.p.A. Human ciliary neuronotrophic factor, DNA sequence encoding the factor, and production of the factor by recombinant technology
US6169074B1 (en) 1996-03-18 2001-01-02 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
ES2160485B1 (es) * 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
JP4769709B2 (ja) * 2003-05-08 2011-09-07 ディーエスエム アイピー アセッツ ビー．ブイ． 皮膚の構造を改善するために美容上適用するためのトリペプチドおよびその誘導体
ES2293753B1 (es) * 2004-04-28 2009-03-16 Lipotec, S.A. Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular.
ES2362301T3 (es) * 2005-03-03 2011-07-01 Revance Therapeutics, Inc. Composiciones y procedimientos para aplicaciones tópicas y liberación transdérmica de un oligopéptido.
ES2259928B1 (es) * 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
US7807625B2 (en) * 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition

Also Published As

Publication number Publication date
AU2007310796A1 (en) 2008-05-02
BRPI0717376B8 (pt) 2021-05-25
RS55755B1 (sr) 2017-07-31
CN101541831A (zh) 2009-09-23
JP2010507632A (ja) 2010-03-11
HRP20170378T1 (hr) 2017-05-05
CA2666516A1 (en) 2008-05-02
ES2322882A1 (es) 2009-06-30
HK1132999A1 (en) 2010-03-12
CN101541831B (zh) 2015-04-01
CL2007003054A1 (es) 2008-03-24
BRPI0717376A2 (pt) 2013-10-29
KR101606448B1 (ko) 2016-03-25
EP2123673A1 (en) 2009-11-25
HUE031340T2 (en) 2017-07-28
RU2009114804A (ru) 2010-11-27
CA2666516C (en) 2017-06-13
SI2123673T1 (sl) 2017-07-31
AR063528A1 (es) 2009-01-28
EP2123673B1 (en) 2016-12-07
DK2123673T3 (en) 2017-03-20
KR20090090307A (ko) 2009-08-25
ZA200903236B (en) 2010-07-28
PT2123673T (pt) 2017-03-01
TW200833365A (en) 2008-08-16
JP5647413B2 (ja) 2014-12-24
US9464129B2 (en) 2016-10-11
AU2007310796B2 (en) 2013-10-10
ES2322882B1 (es) 2010-04-22
IL198191A (en) 2016-07-31
NZ576373A (en) 2011-11-25
IL198191A0 (en) 2011-08-01
RU2461568C2 (ru) 2012-09-20
LT2123673T (lt) 2017-03-27
ES2638286T3 (es) 2017-10-19
CY1118690T1 (el) 2017-07-12
WO2008049945A1 (es) 2008-05-02
US20100021510A1 (en) 2010-01-28
TWI439291B (zh) 2014-06-01
MX2009004424A (es) 2009-05-11
EP2123673A4 (en) 2011-01-12
BRPI0717376B1 (pt) 2018-07-24

Similar Documents

Publication Publication Date Title
IL198191A0 (en) Neuronal exocytosis inhibiting peptides
GB2441224B (en) Dust-extracting system
EP2084843A4 (en) BIOMETRIC SYSTEMS
GB201112625D0 (en) Sensor system
EP2017283A4 (en) Peptides
EP2021364A4 (en) IMPROVED ANTIMICROBIAL PEPTIDES
GB0723712D0 (en) Peptides
PL2125871T3 (pl) Peptydy o działaniu przeciwbakteryjnym
EP2029448A4 (en) TRANSPORT APPARATUS
PL2059451T3 (pl) System zamykania
PL2008251T3 (pl) Element zabezpieczający
EP2123666A4 (en) PEPTIDE
GB0602276D0 (en) System
GB0703945D0 (en) Peptide
GB0618748D0 (en) Peptide
GB0616494D0 (en) Armour
IL197675A0 (en) Peptides
GB0614336D0 (en) System
GB0621015D0 (en) Seismography system
GB0605774D0 (en) Peptide
IL178840A0 (en) System
GB0607805D0 (en) Fluxion system
GB0618512D0 (en) Peptides
GB0609921D0 (en) Peptides
GB0625176D0 (en) Peptides